Cas:304669-35-0 (5,6-Dihydro-4H-pyran-2-yl)dimethylsilanol manufacturer & supplier

We serve Chemical Name:(5,6-Dihydro-4H-pyran-2-yl)dimethylsilanol CAS:304669-35-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

(5,6-Dihydro-4H-pyran-2-yl)dimethylsilanol

Chemical Name:(5,6-Dihydro-4H-pyran-2-yl)dimethylsilanol
CAS.NO:304669-35-0
Synonyms:(3,4-Dihydro-2H-pyran-6-yl)dimethylsilanol;MFCD09265116;3,4-dihydro-2H-pyran-6-yl-hydroxy-dimethylsilane
Molecular Formula:C7H14O2Si
Molecular Weight:158.27000
HS Code:2932999099

Physical and Chemical Properties:
Melting point:N/A
Boiling point:236.1ºC at 760mmHg
Density:1.005
Index of Refraction:1.475
PSA:29.46000
Exact Mass:158.07600
LogP:1.41730

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like (3,4-Dihydro-2H-pyran-6-yl)dimethylsilanol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3,4-dihydro-2H-pyran-6-yl-hydroxy-dimethylsilane physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(3,4-Dihydro-2H-pyran-6-yl)dimethylsilanol Use and application,MFCD09265116 technical grade,usp/ep/jp grade.


Related News: AstraZeneca’s deal, the largest struck last year, is all part of CEO Pascal Soriot’s mission to hit $40 billion in global sales by 2023. 5-(3,5-dichloro-4-methoxy-phenyl)-[1,3,4]oxadiazole-2-carbonitrile manufacturers “The acquisition of Vanamali Organics represents the next stage of this investment strategy,” Wavelength CEO Iftach Seri said in a statement. ” We are delighted to add their talented team and advanced development and manufacturing capabilities to Wavelength, and we expect they will be important contributors to our global supply chain network and our rapidly growing custom development and manufacturing services business.” N-formyl-N-(o-allylphenyl)alanine suppliers CHMP also recommended for approval Sanofi and Genzyme’s new Pompe disease drug, known in Europe as Nexviadyme (avalglucosidase alfa). Pompe disease is a rare, inherited disorder caused by the buildup of glycogen in the body’s cells. 1′,1′,1′,1′,8,12,16,18-octamethyldispiro(1,6,20,25-tetraoxa(6.1.6.1)paracyclophane-13,4′:32,4′-bispiperidinium) dichloride vendor & factory.